Form 4: Hanover Bancorp President McClelland W. Wilcox Receives Stock Grant
SEC Form 4 Filing
McClelland W. Wilcox, President of Hanover Bancorp, Inc., reports the acquisition of 5,228 shares of common stock through a restricted stock grant.
Summary
- McClelland W. Wilcox, President of Hanover Bancorp, Inc., filed a Form 4 on January 31, 2025, reporting a transaction that occurred on January 29, 2025.
- The transaction involved the acquisition of 5,228 shares of Hanover Bancorp common stock.
- These shares were acquired through a grant of restricted stock.
- The restricted stock vests over a five-year period, with 1/5 vesting annually on February 20th, starting in 2026 and ending in 2030.
- Following the reported transaction, Wilcox beneficially owns 86,765 shares of Hanover Bancorp common stock.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. The sentiment is neutral to positive.
Positives
- The grant of restricted stock aligns the President's interests with the long-term performance of the company.
- The vesting schedule encourages continued service and contribution to Hanover Bancorp over the next five years.
Future Outlook
The vesting schedule of the restricted stock grant suggests an expectation of continued service and contribution from the President over the next five years.
Industry Context
Stock grants are a common form of executive compensation in the banking industry, used to incentivize performance and align management interests with shareholder value.
Comparison to Industry Standards
- Executive compensation packages, including stock grants, are typically benchmarked against peer institutions of similar size and scope.
- Companies like New York Community Bancorp (NYCB) and Valley National Bancorp (VLY) also utilize stock grants as part of their executive compensation strategy.
- The vesting schedule and grant size are often determined based on industry standards and company-specific performance metrics.
Stakeholder Impact
- Shareholders may view the stock grant positively as it aligns management's interests with long-term company performance.
- Employees may see the grant as a sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 01/29/2025 | Date of stock grant transaction |
| 01/31/2025 | Date Form 4 was filed |
| 02/20/2026 | First vesting date for restricted stock (1/5 of shares) |
| 02/20/2027 | Second vesting date for restricted stock (1/5 of shares) |
| 02/20/2028 | Third vesting date for restricted stock (1/5 of shares) |
| 02/20/2029 | Fourth vesting date for restricted stock (1/5 of shares) |
| 02/20/2030 | Final vesting date for restricted stock (1/5 of shares) |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.